2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $405M | $427M | $458M | $483M | $568M |
Cost of Revenue | $252M | $257M | $282M | $282M | $334M |
Gross Profit | $153M | $171M | $176M | $201M | $233M |
Gross Profit % | 38% | 40% | 38% | 42% | 41% |
R&D Expenses | $9.3M | $12M | $8.7M | $7M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $38M | $13M | $5.8M | $39M | $36M |
Dep. & Amort. | $15M | $14M | $16M | $16M | $16M |
Def. Tax | -$12M | $4.8M | -$1.1M | -$210K | -$2.1M |
Stock Comp. | $0 | $355K | $32M | $9.4M | $8.4M |
Chg. in WC | $17M | -$9.7M | -$13M | $10M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $2.9M | $34M | $45M | $88M | $125M |
ST Investments | $0 | $0 | $3.6M | $3.7M | $0 |
Cash & ST Inv. | $2.9M | $34M | $45M | $88M | $125M |
Receivables | $44M | $48M | $65M | $58M | $94M |
Inventory | $61M | $64M | $70M | $81M | $82M |
CADRE reported strong Q4 and full-year 2024 results, achieving record quarterly revenue, gross margin, adjusted EBITDA, and adjusted EBITDA margin. Full-year revenue grew 18%, and adjusted EBITDA grew 22%, with a 70 basis point improvement in adjusted EBITDA margin year-over-year.
The company announced the acquisition of the engineering division from KARS Group, expanding its nuclear safety vertical and international footprint. This acquisition is expected to close in Q2 2025 and adds complementary brands to CADRE's portfolio, enhancing its capabilities in automation, robotics, and nuclear medicine.
CADRE provided 2025 guidance with net sales expected between $572M and $601M and adjusted EBITDA between $105M and $115M, reflecting a 2%-5% organic growth range. The guidance does not include impacts from U.S. tariffs or the KARS acquisition.
The company highlighted macro uncertainties in 2025, including potential delays in federal agency transactions due to government downsizing. However, CADRE remains optimistic about long-term growth drivers in public safety and nuclear safety markets.
CADRE continues to generate strong free cash flow, supporting organic growth, M&A objectives, and dividend increases. The company raised its quarterly dividend by 9% to $0.38 per share on an annualized basis.